Who we are

MAGIA2Market – Medtech Alliance for Global InternationAlisation To Market

MAGIA2Market follows the first phase of the MAGIA project and brings together four European leading MedTech clusters: bioPmed / Bioindustry Park Silvano Fumero (coordinator, Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) joining forces to continue the successful European strategic Cluster Partnership on MedTech.

MAGIA2Market aims to provide SMEs the opportunity to meet with potential partners in the USA, China and Japan, laying the groundwork for potential cooperation, both in terms of business agreements but also co-development or research collaboration.

the overall goal of the MAGIA Alliance is to pursue its primary objective: the building and reinforcement of strong networks in its target countries to provide efficient and long-term gateways for SMEs to penetrate these target markets successfully.

your gateway for internationalization

EXPLORE the market-entry opportunities
the MAGIA2Market Alliance has to offer to your company

PREPARE to enter the target markets
with the support of the Alliance

CONNECT with our local partners
for a successful market-entry

Partners of the Alliance

bioPmed / Bioindustry Park Silvano Fumero

bioPmed is the Italian innovation cluster dedicated to health care related products and services.

Established in 2009 by Regione Piemonte and managed by Bioindustry Park Silvano Fumero, the Piedmontese science & technology park specialised in the field. bioPmed brings together companies, research centers, universities, and foundations, working together with a common vision and a shared strategic plan. It promotes research-industry interactions, stimulates innovation, supports valorisation and commercialisation of research results and internationalization.



BioWin is the Health Cluster of Wallonia, Belgium: the regional reference holder for all stakeholders in innovative R&I projects in health biotechnology and medical technology.

The cluster brings together all the innovative players in the field of Life Sciences in Wallonia, with the goal of stimulating regional economic redeployment. Initially, its role was largely focused on the development, selection and monitoring of collaborative Research and Innovation (R&I) projects involving universities, research centers, academic hospitals and industries. Today, BioWin is also involved in implementing the sector’s industrial policy (industrial innovation and research, training, support for business growth, etc.). The purpose of this is to develop and anchor skills, knowledge and jobs.



Life Science Nord

Life Science Nord strengthens the value chain in Hamburg and Schleswig-Holstein and has established itself as one of the leading life science networks in Europe. With a complete value chain, the Life Science Nord cluster offers a unique infrastructure: practically oriented researchers and clinical staff cooperate closely with partners in the industry to help innovative products and technologies make the breakthrough. To support this structure, the cluster agency Life Science Nord Management GmbH and the Life Science Nord e.V. association work together and offer a variety of activities.



The Lyonbiopole cluster unites and structures the innovative, fertile healthcare ecosystem of the Auvergne-Rhône-Alpes region, France. As a global competitiveness cluster since its inception in 2005, it supports the sector’s projects and companies to strengthen the development of technological innovations, products and services to meet tomorrow’s healthcare challenges.

Lyonbiopole currently has 245 members, including four major manufacturers who helped cofound it (Sanofi Pasteur, bioMérieux, Boehringer Ingelheim Animal Health, Becton Dickinson). It is Gold label certified by the European Cluster Excellence Initiative and a member of MAGIA and S3martmed, two major European metaclusters.